Profusa, Inc. (PFSA) stock
PFSANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NVACW
$0.45−0.01 (-2.61%)
Close on Nov 13, 2026Market cap $1.13MP/E –Yield –
Profusa cash
Cash and short-term investments held at the end of each period.
Profusa's cash was $8.40M at Sep 30, 2026. For fiscal 2025 it was $1.78M, up 830.9% from the year before. The highest annual figure on record is $1.78M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.78M | +830.9% |
| FY2024 | Dec 31, 2024 | $191.00K | +34.5% |
| FY2023 | Dec 31, 2023 | $142.00K | -26.6% |
| FY2022 | Dec 31, 2022 | $193.49K | -73.9% |
| FY2021 | Dec 31, 2021 | $741.23K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $8.40M | +179.2% |
| Q2 FY2026 | Jun 30, 2026 | $12.20M | +31182.1% |
| Q1 FY2026 | Mar 31, 2026 | $375.00K | +1873.7% |
| Q4 FY2025 | Dec 31, 2025 | $1.78M | +830.9% |
| Q3 FY2025 | Sep 30, 2025 | $3.01M | +2049.3% |
| Q2 FY2025 | Jun 30, 2025 | $39.00K | +500.4% |
| Q1 FY2025 | Mar 31, 2025 | $19.00K | +257.5% |
| Q4 FY2024 | Dec 31, 2024 | $191.00K | +34.5% |
| Q3 FY2024 | Sep 30, 2024 | $140.00K | +707.3% |
| Q2 FY2024 | Jun 30, 2024 | $6.50K | +11.8% |
| Q1 FY2024 | Mar 31, 2024 | $5.31K | -90.4% |
| Q4 FY2023 | Dec 31, 2023 | $142.00K | -26.6% |
| Q3 FY2023 | Sep 30, 2023 | $17.34K | -95.3% |
| Q2 FY2023 | Jun 30, 2023 | $5.81K | -98.8% |
| Q1 FY2023 | Mar 31, 2023 | $55.61K | -89.1% |
| Q4 FY2022 | Dec 31, 2022 | $193.49K | -73.9% |
| Q3 FY2022 | Sep 30, 2022 | $372.87K | – |
| Q2 FY2022 | Jun 30, 2022 | $480.73K | – |
| Q1 FY2022 | Mar 31, 2022 | $510.88K | – |
| Q4 FY2021 | Dec 31, 2021 | $741.23K | – |
See a number that looks wrong?